IL68095A - Pyridinecarboxylic acid esters,their preparation and pharmaceutical compositions containing them - Google Patents
Pyridinecarboxylic acid esters,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL68095A IL68095A IL68095A IL6809583A IL68095A IL 68095 A IL68095 A IL 68095A IL 68095 A IL68095 A IL 68095A IL 6809583 A IL6809583 A IL 6809583A IL 68095 A IL68095 A IL 68095A
- Authority
- IL
- Israel
- Prior art keywords
- acid esters
- pyridinecarboxylic acid
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
- Drawers Of Furniture (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823209274 DE3209274A1 (de) | 1982-03-13 | 1982-03-13 | Pyridincarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL68095A true IL68095A (en) | 1986-12-31 |
Family
ID=6158229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL68095A IL68095A (en) | 1982-03-13 | 1983-03-10 | Pyridinecarboxylic acid esters,their preparation and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4705794A (fi) |
| EP (1) | EP0088940B1 (fi) |
| JP (1) | JPS58167571A (fi) |
| KR (1) | KR910000637B1 (fi) |
| AT (1) | ATE19875T1 (fi) |
| AU (1) | AU564367B2 (fi) |
| CA (1) | CA1208216A (fi) |
| DE (2) | DE3209274A1 (fi) |
| DK (1) | DK157857C (fi) |
| FI (1) | FI82687C (fi) |
| GR (1) | GR78454B (fi) |
| HU (1) | HU188851B (fi) |
| IE (1) | IE54879B1 (fi) |
| IL (1) | IL68095A (fi) |
| NO (1) | NO162234C (fi) |
| PH (1) | PH19685A (fi) |
| PT (1) | PT76328B (fi) |
| ZA (1) | ZA831691B (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58185821U (ja) * | 1982-06-02 | 1983-12-10 | 日産自動車株式会社 | ウインドシ−ルド |
| DE4342196A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Neue 4-Phenyl-substituierte 1,4-Dihydropyridine |
| DE3410645A1 (de) * | 1984-03-23 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| GB8530602D0 (en) * | 1985-12-12 | 1986-01-22 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
| IT1204948B (it) * | 1987-03-13 | 1989-03-10 | Boheringer Biochemia Robin S P | 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono. |
| DE3712371A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung |
| DE3712369A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung |
| CA1312611C (en) * | 1987-07-01 | 1993-01-12 | Yamanouchi Pharmaceutical Co., Ltd. | Pyridine derivatives, process for production thereof and pharmaceutical composition containing them |
| US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
| EP0657432B1 (de) * | 1993-12-10 | 2003-03-12 | Bayer Ag | Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität |
| DE4430639A1 (de) | 1994-08-29 | 1996-03-07 | Bayer Ag | Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten |
| WO2005025507A2 (en) * | 2003-09-10 | 2005-03-24 | Synta Phamaceuticals Corp. | Dihydropyridine compounds for treating or preventing metabolic disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3209276A1 (de) * | 1982-03-13 | 1983-09-15 | Bayer Ag, 5090 Leverkusen | Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung |
-
1982
- 1982-03-13 DE DE19823209274 patent/DE3209274A1/de not_active Withdrawn
-
1983
- 1983-02-17 NO NO830539A patent/NO162234C/no unknown
- 1983-02-28 US US06/470,886 patent/US4705794A/en not_active Expired - Fee Related
- 1983-03-02 DE DE8383102001T patent/DE3363581D1/de not_active Expired
- 1983-03-02 EP EP83102001A patent/EP0088940B1/de not_active Expired
- 1983-03-02 AT AT83102001T patent/ATE19875T1/de active
- 1983-03-03 PT PT76328A patent/PT76328B/pt unknown
- 1983-03-07 AU AU12081/83A patent/AU564367B2/en not_active Ceased
- 1983-03-10 FI FI830810A patent/FI82687C/fi not_active IP Right Cessation
- 1983-03-10 IL IL68095A patent/IL68095A/xx unknown
- 1983-03-11 CA CA000423460A patent/CA1208216A/en not_active Expired
- 1983-03-11 GR GR70766A patent/GR78454B/el unknown
- 1983-03-11 HU HU83847A patent/HU188851B/hu not_active IP Right Cessation
- 1983-03-11 PH PH28638A patent/PH19685A/en unknown
- 1983-03-11 ZA ZA831691A patent/ZA831691B/xx unknown
- 1983-03-11 JP JP58039303A patent/JPS58167571A/ja active Granted
- 1983-03-11 KR KR1019830000979A patent/KR910000637B1/ko not_active IP Right Cessation
- 1983-03-11 IE IE535/83A patent/IE54879B1/en not_active IP Right Cessation
- 1983-03-11 DK DK117783A patent/DK157857C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT76328A (en) | 1983-04-01 |
| FI82687B (fi) | 1990-12-31 |
| DK157857C (da) | 1990-07-30 |
| FI82687C (fi) | 1991-04-10 |
| HU188851B (en) | 1986-05-28 |
| NO830539L (no) | 1983-09-14 |
| PH19685A (en) | 1986-06-13 |
| DK157857B (da) | 1990-02-26 |
| FI830810A0 (fi) | 1983-03-10 |
| JPS58167571A (ja) | 1983-10-03 |
| KR910000637B1 (ko) | 1991-01-31 |
| DE3363581D1 (en) | 1986-06-26 |
| AU564367B2 (en) | 1987-08-13 |
| GR78454B (fi) | 1984-09-27 |
| DK117783A (da) | 1983-09-14 |
| EP0088940A1 (de) | 1983-09-21 |
| NO162234B (no) | 1989-08-21 |
| PT76328B (en) | 1985-11-11 |
| DE3209274A1 (de) | 1983-09-15 |
| IE54879B1 (en) | 1990-03-14 |
| ZA831691B (en) | 1983-12-28 |
| AU1208183A (en) | 1983-09-15 |
| DK117783D0 (da) | 1983-03-11 |
| KR840004079A (ko) | 1984-10-06 |
| US4705794A (en) | 1987-11-10 |
| NO162234C (no) | 1989-11-29 |
| ATE19875T1 (de) | 1986-06-15 |
| CA1208216A (en) | 1986-07-22 |
| FI830810L (fi) | 1983-09-14 |
| EP0088940B1 (de) | 1986-05-21 |
| IE830535L (en) | 1983-09-13 |
| JPH0551581B2 (fi) | 1993-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3363244D1 (en) | Compounds, process for their preparation and their use as pharmaceutical preparations | |
| DE3069408D1 (en) | 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them | |
| ES8801787A1 (es) | Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos | |
| ES8404993A1 (es) | Procedimiento para preparar derivados de piridina | |
| FI831009A0 (fi) | Spiro/4(3+n)/-2-aza-3-karboxylsyra-derivat, foerfarande foer deras framstaellning, dessa innehaollaaemnen och deras anvaendning | |
| DK159148C (da) | Analogifremgangsmaade til fremstilling af tranexamsyrederivater | |
| ES2000185A6 (es) | Procedimiento para preparar derivados de acidos piridoncaboxilicos | |
| IL68095A (en) | Pyridinecarboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
| GB1058984A (en) | Indolyl amides | |
| ES8501363A1 (es) | Procedimientos de obtencion de amidoaminoacidos y similares. | |
| ES8401456A1 (es) | Procedimiento para la preparacion de 2-aminometilfenoles. | |
| ES8103740A1 (es) | Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina | |
| ES448439A1 (es) | Procedimiento para la preparacion de nuevos de diacina. | |
| ES8103047A1 (es) | Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios | |
| IL71430A (en) | 2-imino-n-phenylsulfonyl-imidazolidine derivatives,process for the manufacture thereof and pharmaceutical preparations containing such compounds | |
| DE2963724D1 (en) | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them |